Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0017168 (
gastroesophageal reflux disease
)
11,783
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Sequencing of HIV-1(
GER
) long terminal repeat (LTR) has demonstrated, for the first time in an HIV-1 primary isolate, a
TAR
duplication referred to as TAR1 (nucleotides +1 through +68) and TAR2 (nucleotides +69 through +136). This
TAR
duplication is stable during replication of HIV-1(
GER
) isolate in CEM cells. Analysis of LTR-CAT reporter constructs demonstrated that under Tat transactivation the HIV-1(
GER
)/LTR (containing TAR1 and TAR2) was expressed at a higher level than a similar construct (HIV-1(
GER
)DeltaTAR) containing a single
TAR
sequence. Among the two transcription initiation sites found in the HIV-1(
GER
)/LTR, only the most 5' start site was shown to be functionally active. The predicted secondary structure of the 5'-end mRNAs of HIV-1(
GER
) suggests it may fold into a double
TAR
hairpin which resembles that of HIV-2. Finally, HIV-1(
GER
) Tat protein shows primary sequence similarity with Tat proteins from other isolates of HIV-1 and is apparently unrelated to HIV-2 Tat proteins. This work provides the first evidence of a
TAR
sequence duplication in HIV-1 which increases the efficiency of transactivation by Tat. Copyright 1996 S. Karger AG, Basel
...
PMID:Structural and Functional Properties of HIV-1(GER) TAR Sequences. 1172 80